U.S. Food Stock News

NYSE:ETR
NYSE:ETRElectric Utilities

Is It Too Late To Consider Entergy (ETR) After A 34% One-Year Rally?

If you are wondering whether Entergy stock still offers value after a strong run, this article walks through what the current price might be implying. Entergy closed at US$109.05, with the stock down 3.0% over the past week and 4.9% over the past month, while still showing a 16.2% return year to date and a 34.3% return over the past year. These moves sit against a backdrop where Entergy continues to feature in broader discussions about regulated utilities, grid reliability and long term...
NYSE:AMP
NYSE:AMPCapital Markets

Will Record EPS And Growing AUM Change Ameriprise Financial's (AMP) Long‑Term Strength Narrative?

In the past quarter, Ameriprise Financial reported record adjusted EPS and highlighted solid business momentum, including growth in assets under management and pretax earnings. This combination of record profitability and expanding client assets has supported a more constructive analyst view of Ameriprise’s long‑term business strength. With record adjusted EPS underscoring operational momentum, we’ll now examine how this earnings performance reshapes Ameriprise Financial’s investment...
NYSE:BBAI
NYSE:BBAIIT

BigBear.ai Panama Deal Tests AI Cargo Security Beyond Defense Roots

BigBear.ai Holdings (NYSE:BBAI) has entered a commercial agreement with Panama's largest logistics operator, PTG, to deploy a co-developed International Shipping Compliance application. The new AI-powered platform focuses on international cargo security, with features such as biometric verification, chain-of-custody tracking, and real-time risk intelligence. The rollout is designed to support regulatory compliance and reduce manual workloads for customs officials involved in cross-border...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Why Tempus AI (TEM) Is Up 9.3% After New FDA CDx Approval And AI Platform Upgrades

In late May 2026, Tempus AI received FDA approval for a tumor-only indication for its 648-gene xT CDx companion diagnostic, while also rolling out major AI upgrades across its Next and Hub platforms and launching the ArteraAI Prostate Test within its ecosystem. This combination of regulatory clearance and expanded AI-enabled decision support underscores Tempus AI’s push to make precision oncology testing more accessible, integrated, and clinically actionable across multiple tumor...
NasdaqGS:CINF
NasdaqGS:CINFInsurance

Cincinnati Financial’s Rising Costs Put Profit Margins Under Closer Scrutiny

Cincinnati Financial, ticker NasdaqGS:CINF, is drawing attention as rising expenses have outpaced revenue, pressuring pre-tax profit margins. Recent updates point to profitability slowing compared with insurance peers, raising fresh questions about the company’s near term competitiveness. These developments follow a period when discussion around the stock focused more on valuation and share price than on its underlying cost trends. Cincinnati Financial’s latest operational trends are...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers Squibb’s Mezigdomide Data Reframes Multiple Myeloma Pipeline Story

Bristol Myers Squibb (NYSE:BMY) reported landmark positive Phase 3 SUCCESSOR-2 results for mezigdomide in relapsed or refractory multiple myeloma. The late breaking data, presented at ASCO 2026, showed a statistically and clinically significant improvement in progression free survival. The study used mezigdomide, a next generation CELMoD, in combination with standard therapy for patients with limited treatment options. The news around mezigdomide comes as Bristol Myers Squibb trades at...
NYSE:KD
NYSE:KDIT

Is Kyndryl Holdings (KD) Offering Opportunity After A 68% Twelve Month Share Price Fall

This article examines whether Kyndryl Holdings at around US$12.47 is a bargain or a value trap, and explores what the current price might be implying. The stock has risen 1.5% over the past week, but is down 10.8% over the past month, 51.1% year to date and 68.1% over the last 12 months. These moves may have changed how investors view both its potential and its risks. Recent coverage has focused on Kyndryl as a standalone IT services specialist following its spin out from IBM, with attention...
NasdaqGS:LI
NasdaqGS:LIAuto

Assessing Li Auto (NasdaqGS:LI) Valuation After New Model Launch Margin Pressures And Share Buybacks

Li Auto (NasdaqGS:LI) is back in focus after a busy week that combined operational updates, capital returns and governance changes, giving investors fresh information on the company’s direction and current risk profile. See our latest analysis for Li Auto. Despite the busy week of earnings, guidance and governance updates, Li Auto’s share price has been under pressure, with a 1-month share price return of 15.44% down and a 1-year total shareholder return of 47.04% down. This suggests that...
NYSE:AJG
NYSE:AJGInsurance

Is Arthur J. Gallagher (AJG) Now Attractive After A 41% One Year Share Price Fall?

If you are wondering whether Arthur J. Gallagher is starting to look better value after a weak share price patch, this article walks through what the current price might be implying about the stock. The stock last closed at US$201.11, with the share price down 1.8% over the past week, down 5.1% over the past month, and down 21.4% year to date, contributing to a 41.5% decline over the past year and a 45.8% gain over five years. These moves sit against a backdrop of ongoing interest in large...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Strength And Long Term Gains

Amneal Pharmaceuticals (AMRX) is back in focus after recent trading that left the stock with a 1 day gain of 1.7% and a 7 day move of 6.0%, prompting fresh attention from investors. See our latest analysis for Amneal Pharmaceuticals. Zooming out, the recent 6.0% 7 day share price return comes after a modest 30 day gain of 2.9% and a 90 day share price decline of 4.6%. However, the 1 year total shareholder return of 79.9% and 3 year total shareholder return of more than 4x suggest momentum has...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

Equinix Geo Zones Targets Data Sovereignty As Stock Trades Below Targets

Equinix launched Equinix Fabric Geo Zones, a global multi-cloud data sovereignty solution designed to enforce geographic boundaries at the network level. The new capability is aimed at helping customers address tightening data regulations such as GDPR in Europe and LGPD in Brazil. Equinix Fabric Geo Zones focus on secure, compliant cloud connectivity for workloads that cross regional and national borders. For investors watching NasdaqGS:EQIX, this product launch comes with the stock trading...
NasdaqGS:RKLB
NasdaqGS:RKLBAerospace & Defense

Rocket Lab Wins Key US$816m SDA Role As Valuation Risk Grows

Rocket Lab passed the System Requirements Review for the Space Development Agency's Tracking Layer Tranche 3 missile tracking constellation. The review confirms its technical solution meets the program's needs and sets Rocket Lab's approach as the baseline for the project. This positions Rocket Lab as prime contractor on an $816m U.S. national security space contract that is still in early program stages. For investors watching NasdaqGS:RKLB, this milestone follows a very strong share price...
NYSE:GCO
NYSE:GCOSpecialty Retail

Genesco (GCO) Returns To Trailing Profitability But Q1 Loss Rekindles Earnings Volatility Debate

Genesco (GCO) opened fiscal Q1 2027 with revenue of US$487.0 million and a basic EPS loss of US$1.42, while trailing 12 month revenue stood at US$2.4 billion with basic EPS of US$1.90. Over recent periods, quarterly revenue has moved between US$474.0 million and US$799.9 million, and quarterly EPS has ranged from a loss of US$2.02 to a profit of US$4.60, giving investors a wide set of outcomes to weigh against the latest print. With the share price around US$38.37, a key question now is how...
NasdaqGM:RICK
NasdaqGM:RICKHospitality

RCI Hospitality Holdings (RICK) Q2 Loss Challenges Bull Narratives On Earnings Quality

RCI Hospitality Holdings (RICK) just posted Q2 2026 revenue of US$68.7 million, with a basic EPS loss of US$0.04 and net income excluding extra items showing a loss of US$0.3 million, keeping the trailing twelve month figures at revenue of US$281.6 million and a net loss of US$6.5 million. Over recent quarters, total revenue has moved within a tight band between US$65.9 million and US$71.5 million while EPS has swung from a profit of US$1.01 in Q1 2025 to quarterly losses through late 2025...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Rhythm Algorithm Aims To Clarify Bardet Biedl Diagnosis And Market Potential

Rhythm Pharmaceuticals (NasdaqGM:RYTM) has published a new evidence-based diagnostic algorithm for Bardet-Biedl syndrome. The algorithm is designed to streamline and accelerate clinical diagnosis of this rare obesity disorder. The update incorporates recent advances in genetic testing to support earlier and more accurate identification of BBS. Rhythm Pharmaceuticals focuses on treatments for rare genetic forms of obesity, and Bardet-Biedl syndrome is a core part of that remit. A clearer...
NasdaqGS:DPZ
NasdaqGS:DPZHospitality

A Look At Domino's Pizza (DPZ) Valuation As Recent Share Price Weakness Draws Investor Attention

Why Domino's Pizza (DPZ) stock is drawing attention now Domino's Pizza (DPZ) is back in focus after a stretch of weaker share performance, with the stock down over the past week, month, and past 3 months. This has prompted investors to reassess its current valuation. See our latest analysis for Domino's Pizza. At a share price of $310.58, Domino's Pizza has seen its short term share price momentum fade, with the stock down 6.54% over the past 30 days and the 1 year total shareholder return...
NYSE:PKE
NYSE:PKEAerospace & Defense

Park Aerospace (PKE) Q4 EPS Surge Challenges Concerns Over Rich Valuation

Park Aerospace (PKE) has capped FY 2026 with fourth quarter revenue of US$24.2 million and basic EPS of US$0.19, set against a trailing twelve month EPS of US$0.56 that reflects 91.1% earnings growth over the last year. Over recent quarters, revenue has moved from US$16.9 million in Q4 FY 2025 to US$24.2 million in Q4 FY 2026, while basic EPS has shifted from US$0.06 to US$0.19, alongside trailing twelve month net profit margins rising from 9.5% to 15.4%. For investors, this combination of...
NYSE:ORA
NYSE:ORARenewable Energy

A Look At Ormat Technologies (ORA) Valuation After Strong Recent Share Price Momentum

Why Ormat Technologies Is On Investors’ Radar Ormat Technologies (ORA) has drawn investor attention after a strong share price move over the past month and past 3 months, prompting a closer look at how the stock lines up with its fundamentals. See our latest analysis for Ormat Technologies. At a share price of US$137.23, Ormat Technologies has seen strong recent momentum, with a 30 day share price return of 24.39% and a 90 day gain of 32.33%. The 1 year total shareholder return of 85.44% and...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

Is It Too Late To Consider Photronics (PLAB) After A 93% One-Year Surge

Here we explore whether Photronics at US$32.34 still offers value after a strong run, or whether most of the opportunity is already priced in. The stock is up 93.5% over the past year, even though it has fallen 37.2% over the last week, 32.3% over the past month, and is down 3.2% year to date. These moves can influence how you think about both risk and potential upside. Recent headlines around semiconductor demand, capacity build outs, and renewed interest in chip supply chains help frame...
NYSE:PD
NYSE:PDSoftware

PagerDuty (PD) Profitability Inflection Challenges Bearish Earnings Decline Narratives

PagerDuty Q1 2027 earnings snapshot PagerDuty (PD) opened its new fiscal year with Q1 2027 revenue of US$121 million and basic EPS of US$0.13, alongside net income excluding extra items of US$10.2 million. The company has seen quarterly revenue move from US$119.8 million in Q1 2026 to a range between US$123.4 million and US$124.8 million through the rest of 2026. Basic EPS shifted from a loss of US$0.07 in Q1 2026 to US$1.72 at its Q3 peak and US$0.13 in the latest quarter. Overall, margins...
NasdaqGS:NAVN
NasdaqGS:NAVNHospitality

Is It Time To Reassess Navan (NAVN) After Its Recent Share Price Rally?

If you are wondering whether Navan at US$21.37 is offering good value or asking too much, you are in the right place. The stock has returned 7.5% over the last 7 days, 24.8% over the last 30 days, and 31.5% year to date, which can change how you think about both upside potential and risk. Recent coverage has focused on Navan's position within the consumer services space and how investors are reacting to its latest corporate updates, including product and platform developments. This context...
NasdaqGS:PTEN
NasdaqGS:PTENEnergy Services

Is Patterson UTI Energy (PTEN) Offering An Opportunity After The Recent Share Price Pullback

If you are wondering whether Patterson-UTI Energy stock still offers value at around US$11.21 per share, this breakdown is designed to help you judge that for yourself. The stock has pulled back around 9.0% over the past week and 9.3% over the past month, even after recording a 73.2% gain year to date and a 114.3% return over the past year. Recent coverage has focused on Patterson-UTI Energy in the context of the wider Energy Services sector. This has included how its share performance...
NasdaqGS:LSCC
NasdaqGS:LSCCSemiconductor

Assessing Lattice Semiconductor (LSCC) Valuation After A Strong Multi‑Month Share Price Rally

Recent share performance and business snapshot Lattice Semiconductor (LSCC) has attracted investor attention after a strong run, with the stock up 27% over the past month and 54% in the past 3 months. The company, valued at about US$20.2b, reports annual revenue of US$574.0m and net income of US$19.9m. It focuses on field programmable gate arrays and related software across communications, industrial, automotive, and consumer markets. See our latest analysis for Lattice Semiconductor. At a...
NYSE:ANF
NYSE:ANFSpecialty Retail

Abercrombie Stock ANF Valuation After Record Q1 Growth Guidance Reaffirmation And Ongoing Share Buybacks

Q1 earnings surprise and guidance set the tone Abercrombie & Fitch (ANF) kicked off 2026 with record first quarter net sales of US$1.1b, marking its 14th consecutive quarter of growth. The company beat profit expectations while maintaining full year guidance and continuing its share repurchase program. See our latest analysis for Abercrombie & Fitch. Despite the strong Q1 report and plans for around 130 new store experiences, Abercrombie & Fitch's share price is down 37.6% year to date and...